A prospective ransomised study of the potential benefits of thoracic epidural anesthesia and analgesia in patients undergoing coronary bypass grafting

N. B. Scott, D. J. Turfrey, John David Norrie

    Research output: Contribution to journalArticle

    242 Citations (Scopus)

    Abstract

    We performed an open, prospective, randomized, controlled study of the incidence of major organ complications in 420 patients undergoing routine coronary artery bypass. graft surgery with or without thoracic epidural anesthesia and analgesia (TEA). All patients received a standardized general anesthetic. Group TEA received TEA for 96 h. Group GA (general anesthesia) received narcotic analgesia for 72 h. Both groups received supplementary oral analgesia. Twelve patients were excluded-eight in Group TEA and four in Group GA-because of incomplete data collection. New supraventricular arrhythmias occurred in 21 of 206 patients (10.2%) in Group TEA compared with 45 of 202 patients (22.3%) in Group GA (P = 0.0012). Pulmonary function (maximal inspiratory lung volume) was better in Group TEA in a subset of 93 patients (P < 0.0001). Extubation was achieved earlier (P < 0.0001) and with significantly fewer lower respiratory tract infections in Group TEA (TEA = 31 of 206, GA = 59 of 202; P = 0.0007). There were significantly fewer patients with acute confusion (GA = I I of 202, TEA = 3 of 206; P = 0.031) and acute renal failure (GA = 14 of 202, TEA = 4 of 206; P = 0.016) in the TEA group. The incidence of stroke was insignificantly less in the TEA group (GA = 6 of 202, TEA = 2 of 206; P = 0.17). There were no neurologic complications associated with the use of TEA. We conclude that continuous TEA significantly improves the quality of recovery after coronary artery bypass graft surgery compared with conventional narcotic analgesia.

    Original languageEnglish
    Pages (from-to)528-535
    Number of pages7
    JournalAnesthesia and Analgesia
    Volume93
    Issue number3
    DOIs
    Publication statusPublished - 2001

    Keywords

    • CARDIAC-SURGERY
    • HEMODYNAMICS
    • METABOLISM
    • PREVENTION
    • CLONIDINE

    Cite this

    A prospective ransomised study of the potential benefits of thoracic epidural anesthesia and analgesia in patients undergoing coronary bypass grafting. / Scott, N. B.; Turfrey, D. J.; Norrie, John David.

    In: Anesthesia and Analgesia, Vol. 93, No. 3, 2001, p. 528-535.

    Research output: Contribution to journalArticle

    @article{6672dee28f5247719f484e344678a626,
    title = "A prospective ransomised study of the potential benefits of thoracic epidural anesthesia and analgesia in patients undergoing coronary bypass grafting",
    abstract = "We performed an open, prospective, randomized, controlled study of the incidence of major organ complications in 420 patients undergoing routine coronary artery bypass. graft surgery with or without thoracic epidural anesthesia and analgesia (TEA). All patients received a standardized general anesthetic. Group TEA received TEA for 96 h. Group GA (general anesthesia) received narcotic analgesia for 72 h. Both groups received supplementary oral analgesia. Twelve patients were excluded-eight in Group TEA and four in Group GA-because of incomplete data collection. New supraventricular arrhythmias occurred in 21 of 206 patients (10.2{\%}) in Group TEA compared with 45 of 202 patients (22.3{\%}) in Group GA (P = 0.0012). Pulmonary function (maximal inspiratory lung volume) was better in Group TEA in a subset of 93 patients (P < 0.0001). Extubation was achieved earlier (P < 0.0001) and with significantly fewer lower respiratory tract infections in Group TEA (TEA = 31 of 206, GA = 59 of 202; P = 0.0007). There were significantly fewer patients with acute confusion (GA = I I of 202, TEA = 3 of 206; P = 0.031) and acute renal failure (GA = 14 of 202, TEA = 4 of 206; P = 0.016) in the TEA group. The incidence of stroke was insignificantly less in the TEA group (GA = 6 of 202, TEA = 2 of 206; P = 0.17). There were no neurologic complications associated with the use of TEA. We conclude that continuous TEA significantly improves the quality of recovery after coronary artery bypass graft surgery compared with conventional narcotic analgesia.",
    keywords = "CARDIAC-SURGERY, HEMODYNAMICS, METABOLISM, PREVENTION, CLONIDINE",
    author = "Scott, {N. B.} and Turfrey, {D. J.} and Norrie, {John David}",
    year = "2001",
    doi = "10.1097/00000539-200109000-00003",
    language = "English",
    volume = "93",
    pages = "528--535",
    journal = "Anesthesia and Analgesia",
    issn = "0003-2999",
    publisher = "Lippincott Williams and Wilkins",
    number = "3",

    }

    TY - JOUR

    T1 - A prospective ransomised study of the potential benefits of thoracic epidural anesthesia and analgesia in patients undergoing coronary bypass grafting

    AU - Scott, N. B.

    AU - Turfrey, D. J.

    AU - Norrie, John David

    PY - 2001

    Y1 - 2001

    N2 - We performed an open, prospective, randomized, controlled study of the incidence of major organ complications in 420 patients undergoing routine coronary artery bypass. graft surgery with or without thoracic epidural anesthesia and analgesia (TEA). All patients received a standardized general anesthetic. Group TEA received TEA for 96 h. Group GA (general anesthesia) received narcotic analgesia for 72 h. Both groups received supplementary oral analgesia. Twelve patients were excluded-eight in Group TEA and four in Group GA-because of incomplete data collection. New supraventricular arrhythmias occurred in 21 of 206 patients (10.2%) in Group TEA compared with 45 of 202 patients (22.3%) in Group GA (P = 0.0012). Pulmonary function (maximal inspiratory lung volume) was better in Group TEA in a subset of 93 patients (P < 0.0001). Extubation was achieved earlier (P < 0.0001) and with significantly fewer lower respiratory tract infections in Group TEA (TEA = 31 of 206, GA = 59 of 202; P = 0.0007). There were significantly fewer patients with acute confusion (GA = I I of 202, TEA = 3 of 206; P = 0.031) and acute renal failure (GA = 14 of 202, TEA = 4 of 206; P = 0.016) in the TEA group. The incidence of stroke was insignificantly less in the TEA group (GA = 6 of 202, TEA = 2 of 206; P = 0.17). There were no neurologic complications associated with the use of TEA. We conclude that continuous TEA significantly improves the quality of recovery after coronary artery bypass graft surgery compared with conventional narcotic analgesia.

    AB - We performed an open, prospective, randomized, controlled study of the incidence of major organ complications in 420 patients undergoing routine coronary artery bypass. graft surgery with or without thoracic epidural anesthesia and analgesia (TEA). All patients received a standardized general anesthetic. Group TEA received TEA for 96 h. Group GA (general anesthesia) received narcotic analgesia for 72 h. Both groups received supplementary oral analgesia. Twelve patients were excluded-eight in Group TEA and four in Group GA-because of incomplete data collection. New supraventricular arrhythmias occurred in 21 of 206 patients (10.2%) in Group TEA compared with 45 of 202 patients (22.3%) in Group GA (P = 0.0012). Pulmonary function (maximal inspiratory lung volume) was better in Group TEA in a subset of 93 patients (P < 0.0001). Extubation was achieved earlier (P < 0.0001) and with significantly fewer lower respiratory tract infections in Group TEA (TEA = 31 of 206, GA = 59 of 202; P = 0.0007). There were significantly fewer patients with acute confusion (GA = I I of 202, TEA = 3 of 206; P = 0.031) and acute renal failure (GA = 14 of 202, TEA = 4 of 206; P = 0.016) in the TEA group. The incidence of stroke was insignificantly less in the TEA group (GA = 6 of 202, TEA = 2 of 206; P = 0.17). There were no neurologic complications associated with the use of TEA. We conclude that continuous TEA significantly improves the quality of recovery after coronary artery bypass graft surgery compared with conventional narcotic analgesia.

    KW - CARDIAC-SURGERY

    KW - HEMODYNAMICS

    KW - METABOLISM

    KW - PREVENTION

    KW - CLONIDINE

    U2 - 10.1097/00000539-200109000-00003

    DO - 10.1097/00000539-200109000-00003

    M3 - Article

    VL - 93

    SP - 528

    EP - 535

    JO - Anesthesia and Analgesia

    JF - Anesthesia and Analgesia

    SN - 0003-2999

    IS - 3

    ER -